APOLIPOPROTEIN B IS RELATED TO METABOLIC SYNDROME INDEPENDENTLY OF LDL-CHOLESTEROL IN PATIENTS WITH TYPE 2 DIABETES

被引：0
|
作者：
Lim, Y. -H. [1 ]
Yoo, S. Y. [1 ]
Chin, S. O. [1 ]
Lee, S. A. [1 ]
Koh, G. P. [1 ]
机构：
[1] Jeju Natl Univ Hosp, Internal Med, Jeju, South Korea
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2014年 / 106卷
关键词：
D O I：
10.1016/S0168-8227(14)70317-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO022
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [1] Apolipoprotein B Is Related to Metabolic Syndrome Independently of Low Density Lipoprotein Cholesterol in Patients with Type 2 Diabetes
    Lim, Younghyup
    Yoo, Soyeon
    Lee, Sang Ah
    Chin, Sang Ouk
    Heo, Dahee
    Moon, Jae Cheol
    Moon, Shinhang
    Boo, Kiyoung
    Kim, Seong Taeg
    Seo, Hye Mi
    Jwa, Hyeyoung
    Koh, Gwanpyo
    ENDOCRINOLOGY AND METABOLISM, 2015, 30 (02) : 208 - 215
  • [2] LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes
    Wägner, AM
    Jorba, O
    Rigla, M
    Alonso, E
    Ordóñez-Llanos, J
    Pérez, A
    ACTA DIABETOLOGICA, 2002, 39 (04) : 215 - 220
  • [3] LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes
    A.M. Wägner
    O. Jorba
    M. Rigla
    E. Alonso
    J. Ordóñez-Llanos
    A. Pérez
    Acta Diabetologica, 2002, 39 : 215 - 220
  • [4] LDL-cholesterol, apolipoprotein B and cardiovascular risk
    Frey, J
    Couderc, R
    ANNALES DE BIOLOGIE CLINIQUE, 1998, 56 (05) : 517 - 520
  • [5] DISCORDANCE BETWEEN APOLIPOPROTEIN B AND LDL-CHOLESTEROL AND HYPERTENSION RISK AMONG ADULTS WITH AND WITHOUT TYPE 2 DIABETES
    Zeng, Ni
    Lavelle, Kevin
    Manjelievskaia, Janna
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1715 - 1715
  • [6] LDL-CHOLESTEROL AND CARDIOVASCULAR EVENTS IN PATIENTS WITH DIABETES MELLITUS TYPE 2
    Tudor, C.
    Iana, A.
    Jeberean, R. A.
    Petrus, A.
    Buzas, R.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 33 - 34
  • [7] Metabolic Properties of Lowdensity Lipoprotein (LDL) Triglycerides in Patients with Type 2 Diabetes, Comparison with Small Dense LDL-Cholesterol
    Hirano, Tsutomu
    Kodera, Rieko
    Hirashima, Takeshi
    Suzuki, Natsuko
    Aoki, Ema
    Hosoya, Mitsuru
    Oshima, Taito
    Hayashi, Toshiyuki
    Koba, Shinji
    Ohta, Motoko
    Satoh, Noriyuki
    Ito, Yasuki
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2022, 29 (05) : 762 - 774
  • [8] LDL-cholesterol calculation formulas in patients with or without the metabolic syndrome
    Gazi, Irene F.
    Elisaf, Moses
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 119 (03) : 414 - 415
  • [9] ACTION OF PIROZADIL (PEMIX) ON CHOLESTEROL, LDL-CHOLESTEROL AND APOLIPOPROTEIN-A AND APOLIPOPROTEIN-B IN HYPERLIPEMIC PATIENTS
    COROMINAS, A
    CLINICAL TRIALS JOURNAL, 1985, 22 (01) : 84 - 93
  • [10] Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes
    Brinton, Eliot A.
    Triscari, Joseph
    Brudi, Philippe
    Chen, Erluo
    Johnson-Levonas, Amy O.
    Sisk, Christine McCrary
    Ruck, Rae Ann
    MacLean, Alexandra A.
    Maccubbin, Darbie
    Mitchel, Yale B.
    LIPIDS IN HEALTH AND DISEASE, 2016, 15
12345